These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 13004570)

  • 21. Liver function and medroxyprogesterone acetate elimination in man.
    Rautio A
    Biomed Pharmacother; 1984; 38(4):199-204. PubMed ID: 6498308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nonalcoholic fatty liver disease and hepatic cirrhosis: Comparison with viral hepatitis-associated steatosis.
    Haga Y; Kanda T; Sasaki R; Nakamura M; Nakamoto S; Yokosuka O
    World J Gastroenterol; 2015 Dec; 21(46):12989-95. PubMed ID: 26675364
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The deficiency factor in the aetiology of portal cirrhosis in the Punjab; a preliminary report.
    MALLICK SM; ALI S; ANAND BK
    Indian Physician; 1945 Oct; 4():213-8. PubMed ID: 20991348
    [No Abstract]   [Full Text] [Related]  

  • 24. The Distribution of Liver Steatosis, Fibrosis, Steatohepatitis and Inflammation Activity in Alcoholics According to FibroMax Test.
    Gudowska M; Wojtowicz E; Cylwik B; Gruszewska E; Chrostek L
    Adv Clin Exp Med; 2015; 24(5):823-7. PubMed ID: 26768633
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum gamma-glutamyl transpeptidase: its clinical significance.
    Pár A; Mestyán I; Kádas I; Balázs M; Gógl A
    Acta Med Acad Sci Hung; 1976; 33(4):309-19. PubMed ID: 23644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Scintigraphic aspects of hepatic steatosis. Histologic and endoscopic correlations].
    Banciu T; Berinde L; Prodan P; Deutsch G; Tudose N; Berinde L
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1979; 31(1):57-64. PubMed ID: 37571
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of liver disease on red blood cell acetaldehyde in alcoholics and non-alcoholics.
    Uppal R; Rosman A; Hernández R; Baraona E; Lieber CS
    Alcohol Alcohol Suppl; 1991; 1():323-6. PubMed ID: 1845555
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical aspects of alcohol induced liver injury (author's transl)].
    Teschke R; Rauen J; Gellert J; Stutz G; Strohmeyer G
    Leber Magen Darm; 1978 Oct; 8(5):291-8. PubMed ID: 359967
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Fat metabolism in alcoholic cirrhosis. Notes on steatosis].
    TRAISSAC FI
    Cesk Gynekol; 1962 May; 16():316-9. PubMed ID: 13993956
    [No Abstract]   [Full Text] [Related]  

  • 30. Hepatic subcellular distribution of copper in primary biliary cirrhosis. Comparison with other hyperhepatocupric states and review of the literature.
    Owen CA; Dickson ER; Goldstein NP; Baggenstoss AH; McCall JT
    Mayo Clin Proc; 1977 Feb; 52(2):73-80. PubMed ID: 345001
    [No Abstract]   [Full Text] [Related]  

  • 31. Nuclear magnetic resonance imaging of the liver: initial experience.
    Doyle FH; Pennock JM; Banks LM; McDonnell MJ; Bydder GM; Steiner RE; Young IR; Clarke GJ; Pasmore T; Gilderdale DJ
    AJR Am J Roentgenol; 1982 Feb; 138(2):193-200. PubMed ID: 6275694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Coffee - a stimulant for the liver].
    MMW Fortschr Med; 2014 Apr; 156(8):6. PubMed ID: 24851424
    [No Abstract]   [Full Text] [Related]  

  • 33. Assessment of liver fibrosis using transient elastography in patients with alcoholic liver disease.
    Nahon P; Kettaneh A; Tengher-Barna I; Ziol M; de Lédinghen V; Douvin C; Marcellin P; Ganne-Carrié N; Trinchet JC; Beaugrand M
    J Hepatol; 2008 Dec; 49(6):1062-8. PubMed ID: 18930329
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-Alcoholic Fatty Liver Disease in HIV Infection.
    Macías J; Pineda JA; Real LM
    AIDS Rev; 2017; 19(1):35-46. PubMed ID: 28182612
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hepatic steatosis: an emerging cause of cirrhosis in HIV patients].
    Loulergue P; Callard P; Bonnard P; Pialoux G
    Pathol Biol (Paris); 2006 Dec; 54(10):587-90. PubMed ID: 17027188
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Review article: type 2 diabetes and chronic liver disease in the Verona diabetes study.
    Trombetta M; Spiazzi G; Zoppini G; Muggeo M
    Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():24-7. PubMed ID: 16225467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum 25 -- hydroxyvitamin D3 levels in patients with liver disease.
    Sonnenberg A; von Lilienfeld-Toal H; Sonnenberg GE; Rohner HG; Strohmeyer G
    Acta Hepatogastroenterol (Stuttg); 1977 Aug; 24(4):256-8. PubMed ID: 906774
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduced concentration of hepatic alpha-tocopherol in patients with alcoholic liver cirrhosis.
    Bell H; Bjørneboe A; Eidsvoll B; Norum KR; Raknerud N; Try K; Thomassen Y; Drevon CA
    Alcohol Alcohol; 1992 Jan; 27(1):39-46. PubMed ID: 1580927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Epidemiology and natural history of cirrhosis].
    Naveau S; Perlemuter G; Balian A
    Rev Prat; 2005 Sep; 55(14):1527-32. PubMed ID: 16255293
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of the lipogenic pathway in the development of hepatic steatosis.
    Postic C; Girard J
    Diabetes Metab; 2008 Dec; 34(6 Pt 2):643-8. PubMed ID: 19195625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.